Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Musculoskeletal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

DAS (low or remission) · patients with rheumatoid arthritis

Golimumab 50 mg every 4 weeks + MTX leads to higher disease activity (DAS Remission) compared with placebo + MTX (high certainty).

1 finding from 1 review

Golimumab for rheumatoid arthritis 2010 · Cochrane Headline outcomes only
RR 5.12 [1.67, 15.66]
4 studies · 919 participants
High